This HTML5 document contains 6 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
dbpedia-owlhttp://dbpedia.org/ontology/
rdfshttp://www.w3.org/2000/01/rdf-schema#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
dbpediahttp://dbpedia.org/resource/
Subject Item
dbpedia:Darbepoetin_alfa
rdfs:comment
Darbepoetin alfa (rINN) /dɑrbəˈpɔɪtɨn/ is a synthetic form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Darbepoetin is marketed by Amgen under the trade name Aranesp.The drug was approved in September 2001 by the Food and Drug Administration for treatment of anemia in patients with chronic renal failure by intravenous or subcutaneous injection.
dbpedia-owl:atcPrefix
B03
dbpedia-owl:atcSuffix
XA02
dbpedia-owl:casNumber
11096-26-7
dbpedia-owl:drugbank
DB00012
dbpedia-owl:fdaUniiCode
15UQ94PT4P